...
首页> 外文期刊>Journal of pharmaceutical sciences. >Bootstrap method-based estimation of the minimum sample number for obtaining pharmacokinetic parameters in preclinical experiments.
【24h】

Bootstrap method-based estimation of the minimum sample number for obtaining pharmacokinetic parameters in preclinical experiments.

机译:在临床前实验中,基于Bootstrap方法的最小样本数估算以获得药代动力学参数。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Empirically, 3-6 samples at each sampling time point have been used for most preclinical one-point sampling experiments without any theoretical justification. The purpose of the present study is to propose a practical approach to determine the minimum sample number (N(min)) based on Monte Carlo simulation and a bootstrap resampling. A computer program MOMENT(BS), in which a bootstrap resampling algorithm is used to estimate mean and standard deviations of pharmacokinetic parameters, such as area under the curve and mean residence time, was applied to estimate N(min). A new simulation program, MONTE1, was developed to generate simulated data for bootstrap resampling using the model parameters including inter- and/or intra-individual variations. Then, an index, S(2)CV calculated as the sum of the squared coefficient of variation is proposed to determine the N(min). The proposed approach was applied to the actual data in preclinical experiments, and the usefulness of the approach was suggested. An issue that one-point sampling data cannot separately assess inter- and intra-individual variability is discussed.
机译:根据经验,大多数临床前单点采样实验都使用每个采样时间点的3-6个样本,而没有任何理论依据。本研究的目的是提出一种基于蒙特卡洛模拟和自举重采样来确定最小样本数(N(min))的实用方法。应用计算机程序MOMENT(BS),其中使用自举重采样算法来估算药代动力学参数的平均值和标准偏差,例如曲线下的面积和平均停留时间,以估算N(min)。开发了新的仿真程序MONTE1,以使用包括个体间和/或个体内变异的模型参数生成用于引导重采样的模拟数据。然后,提出了作为变异系数平方和之和的指标S(2)CV来确定N(min)。将该方法应用于临床前实验中的实际数据,并提出了该方法的实用性。讨论了单点采样数据无法单独评估个体间和个体内变异性的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号